Evaluation of Nociceptive Processing in the Cervical Region

January 22, 2020 updated by: Josue Fernandez Carnero

Evaluation of Nociceptive Processing in the Cervical Region Through Action Observation, Laterality Discrimination and Exercise

The main objective of this research is to asses the effectivity of action observation therapy, left/right discrimination and therapeutic exercise in the nociceptive processing of the cervical region.

Study Overview

Detailed Description

Neck pain is the fourth cause of loss of years due to disability, behind back pain, depression and joint pain. Studies show that about half of the population will experience at least one episode of the clinically important neck during their life. The vast majority of studies indicate a prevalence of neck pain that varies between 15% and 50%, including a systematic review with a ratio of 37.2%, the investigators can ensure that neck pain is a common pathology among the population. Among the variables associated with neck pain, besides rheumatology, include genetic, psychopathological variables (such as depression, anxiety, coping skills, somatization), sleep disorders, smoking and a sedentary lifestyle, among others. All those variables alter the nervous system in a proprioceptive level, so that deep and superficial flexor, as well as the rest of the muscles, they do not receive correct information that prevents them from processing properly the obtained information. Therefore, alterations also occur at central nervous system levels as in the processing of pain and its control by inhibitory descending systems.

The most used treatment for neck pain is exercise. In a recent Cochrane review conducted by Gross A. et al., It has been proven, despite the shortage of high-quality studies, that the use of exercise routines based on strength and resistance training causes a reduction in pain.

Motor imagery (MI) or graduated motor imagery (GMI) is defined as "the mental and dynamic process of action, without real movement execution" and the action observation (AO) consists in observing an action carried out by another person. These treatments are based on the ability of the nervous system to assimilate the images seen and process them until they reach the motor cortex, and thanks to the mirror neurons, the painful pattern decreases until it disappears. Thus, visualising a painful situation provokes and evokes in the brain, a painful experience, even when this is not actually happening.

Therefore, the interruption of this neural network of cortical proprioceptive representations and integration of motor processes, also known as "body schema", is particularly relevant for movement and manual therapies. One way to measure the current state of the body scheme is through laterality tasks or "left / right judgement task" (LRJT), which have proven to be an effective and reliable tool and can also be used as a treatment.

All of the above facilitates the possibility of using these tools as treatments focused on the cortical area with GMI. However, the effectiveness of MI is controversial. Some studies have been carried out in pathological patients, in a pilot study they confirmed the changes produced in the neck region, both by an increase in the range of movement and an increase in the pain threshold to pressure, focused on the population with chronic neck pain. It is difficult to find studies in healthy patients, although in recent years some publications on motor imagery can be found finding changes in the descending inhibitory systems of pain and its processing. Many variables such as the duration of the sessions, the time per exercise or the type of tasks to be performed, together with the lack of studies on the neck region and the comparison between different tasks and their respective affectation of the descending pain inhibitory systems, have led us to carry out this study.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aravaca
      • Madrid, Aravaca, Spain, 28023
        • Centro Superior de estudios Universitarios La SALLE
    • Madrid
      • Alcorcon, Madrid, Spain, 28922
        • Universidad Rey Juan Carlos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy volunteers.
  • Asymptomatic on cervical region.
  • Understands and accept the informed consent.
  • Spanish speakers.
  • People with no cognitive disorders.

Exclusion Criteria:

  • Pregnant women.
  • Positive neurological signs or evidence of spinal cord compression (abnormal diffuse sensitivity, hyperreflexia or diffuse weakness).
  • Previous cervical surgeries with recurrent symptoms.
  • Previous headaches.
  • Inability to provide informed consent.
  • Cognitive disorders.
  • Reading or verbal misunderstanding when receiving instructions.
  • Having suffered any pain in the last 3 months, both in the quadrant suppressor as in the lumbar region and pelvis.
  • Suffer any pain at the time of the study.
  • Any recent traumatic event, whether physical or psychological / emotional.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Exercise
The subjects perform the exercises provided by the researchers. Which consist of neck exercises in all ranges of movement (inclinations and rotations to both sides), apart from flexion and extension.
Evidence based exercises for the neck.
Experimental: Action Observation
Subjects will watch 30-second videos, with a one-minute break between videos. The videos show the actions that subjects should imagine while watching the video.
Videos of cervical movements.
Experimental: Right/Left Judgment Task

The laterality will be trained with the Recognize® application. Once the subjects have been trained, they are instructed to solve the different sections of the application, starting with the simplest tasks until reaching the most difficult ones.

These tasks would consist of indicating "left" or "right", among the different images that appear on the iPad screen, indicating if the image's neck is rotated to the left or right. Being every level more complicated, so that people of different skin tones, with clothes or in a work environment are added.

It is an application by Noigroup (Neuro Orthopedic Institute), adapted to different devices.
Other Names:
  • Recognise® by Noigroup

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in cervical range of movement.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Measured with goniometer by the physiotherapists.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in pain perception.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Self reported Visual Analog Scale. Minimum value is 0 (best); Maximun value is 10 (worst).
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in the subject's selective attention capacity and skills as well as their processing speed ability.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
It will be measured using the Encephalapp application. The time taken to perform 2 successful trials of 10 images without making an error was recorded.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in pain treshold perception.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Mechanical nociceptive threshold test using Von-Frey filaments.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in upper Limb Neurodinamics.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Upper limb neurodinamics test measuring with a goniometer on what grade of joint movement with nerve stretching pain appears.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in levels of hyperalgesia to pressure and maximum pressure tolerance.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Pressure Pain Tresholds using an algometer on first finger, trapezius muscle and tibia.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in endogenous pain inhibition mechanisms.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Conditioned pain modulation and temporal summation (windup), using the algometer and an oclussion band.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in pain to cold threshold.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Cold stimulation test using cold compresses on the cervical region two times during 10 minutes.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in deep neck flexors activation.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Deep neck flexor endurance test.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in hand and forearm muscular strenght.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Handgrip strenght test using a dynamometer.
Before and after the treatment (2 weeks), after 15 days and after 30 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in levels of Catastrophism.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
13 item Pain Catastrophic Scale that must be answered with a numeric value between 0 (not at all) and 4 (all the time), with a maximum score of 52 points, with higher scores indicating greater pain catastrophizing.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in Kinesiophobia, levels of fear to movement.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
11 item Tampa Scale for Kinesiophobia, the final score can range between 11 and 44 points, with higher scores indicating greater perceived kinesiophobia.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in Fear-avoidance behaviours.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Fear-avoidance Beliefs Questionnaire . The instrument consists of two subscales, a four-item physical activity subscale, and a seven-item work subscale. Each item is scored from 0 to 6 and summed to produce the subscale score. Possible scores range from 0-28 to 0-42, with higher scores indicating greater fear avoidance beliefs.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in level of Depression.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
Beck's Depression Inventory II is a 21-item self-reporting questionnaire. It scores from 0 to 21, the higher is the score the higher is the level of depression.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in patient's anxiety.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
State-Trait Anxiety Inventory. The total score ranges from 0-63 interpreted as follows: 0-9, normal or no anxiety; 10-18, mild to moderate anxiety; 19-29, moderate to severe anxiety; and 30-63, severe anxiety.
Before and after the treatment (2 weeks), after 15 days and after 30 days.
Changes in the ability to generate mental motor images.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
The Movement Imagery Questionnaire-Revised. It is an 8-item self-reporting inventory rating the difficulty of generating that image on a 7-point scale, where 1 indicates 'very difficult to see/feel' and 7 indicates 'very easy to see/feel'.
Before and after the treatment (2 weeks), after 15 days and after 30 days.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity of the patients.
Time Frame: Before and after the treatment (2 weeks), after 15 days and after 30 days.
International physical activity questionnaire. Results are reported in categories depending on the variable 'MET minutes a week'. MET minutes represent the amount of energy expended carrying out physical activity. High physical activity (one hour of more of physical activity per day), moderate physical activity (half an hour of physical activity per day) or low physical activity (not meeting any of the criteria for either moderate or high levels of physical activity).
Before and after the treatment (2 weeks), after 15 days and after 30 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Morales Tejera, Msc., Phdc, Universidad Rey Juan Carlos

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2018

Primary Completion (Actual)

July 30, 2019

Study Completion (Actual)

December 30, 2019

Study Registration Dates

First Submitted

December 20, 2019

First Submitted That Met QC Criteria

January 22, 2020

First Posted (Actual)

January 27, 2020

Study Record Updates

Last Update Posted (Actual)

January 27, 2020

Last Update Submitted That Met QC Criteria

January 22, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • URJC-07/2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Neck

Clinical Trials on Action Observation

3
Subscribe